Grunenthal

News

Grünenthal buys into Kyowa Kirin's mature medicines portfoli...

German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan's Kyowa Kirin, which are currently sold by affiliate companies across Europe.<

News

Grünenthal takes non-opioid pain drug resiniferatoxin into p...

Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of

News

Bayer sells testosterone drug rights to Grünenthal for €500m

Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business.